About DIAGNOSTEAR TECHNOLOGIES INC.
Sector
Industry
CEO
Ohad David
Website
Headquarters
Vancouver
Founded
2023
FIGI
BBG01R4ZYGG7
DiagnosTear Technologies, Inc. operates as an ophthalmic company, which engages in the developing and commercializing disruptive diagnostic solutions for better management of eye diseases. The company was founded on May 10, 2023 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DTR is 0.500 CAD — it has decreased by −11.11% in the past 24 hours. Watch DIAGNOSTEAR TECHNOLOGIES INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange DIAGNOSTEAR TECHNOLOGIES INC. stocks are traded under the ticker DTR.
DTR stock has fallen by −19.19% compared to the previous week, the month change is a −43.66% fall, over the last year DIAGNOSTEAR TECHNOLOGIES INC. has showed a −29.58% decrease.
No, DTR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DTR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAGNOSTEAR TECHNOLOGIES INC. stock right from TradingView charts — choose your broker and connect to your account.